Clorox (CLX) Tops Q2 EPS by 9c; Boosts Outlook Modestly

Clorox (NYSE: CLX) reported Q2 EPS of $1.14, $0.09 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.35 billion.

GUIDANCE:

Clorox sees FY2016 EPS of $4.75-$4.90, versus prior guidance of $4.68-$4.83 and the consensus of $4.88.

"Our strategy continues to drive profitable growth," said Chief Executive Officer Benno Dorer. "We delivered 18 percent earnings growth supported by strong operational execution and commodity tailwinds, helping to drive gross margin expansion. Importantly, we also delivered sales increases in each of our U.S. segments behind continued strong investments in our brands."

For earnings history and earnings-related data on Clorox (CLX) click here.

You May Also Be Interested In

• Intuitive Surgiical (ISRG) beats earnings, revenue expectations in Q1
• Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
• Five Point Holdings, LLC (FPH) Reports Q1 EPS of $0.03